Literature DB >> 20101413

Two families with compound heterozygosity for adenine phosphoribosyltransferase deficiency.

Takuma Iwaki1, Takashi Kusaka, Ikuko Ohashi, Tomoko Nishida, Tadashi Imai, Susumu Itoh.   

Abstract

Adenine phosphoribosyltransferase deficiency is a disorder in which 2,8-dihydroxyadenine (2,8-DHA) crystalluria is caused by a congenital deficiency in the enzyme adenine phosphoribosyltransferase (APRT). In most cases, APRT deficiency is caused by autosomal recessive inheritance of a homozygote of the mutant gene APRT*Q0 or APRT*J, but there are also some cases in which the disorder is caused by the compound heterozygote APRT*Q0 and APRT*J. In the patients described here, brown round crystals were found in their urinary sediment. Crystalluria was the first sign of APRT deficiency, thereafter confirmed by genetic screening for APRT*/Q0 and APRT*. We performed genetic screening for APRT*Q0 and APRT*J in two families and diagnosed three cases of APRT*Q0 /APRT*J compound heterozygote-type APRT deficiency. Genetic screening for APRT*Q0 and APRT*J of family members is effective for early diagnosis and early treatment for family members.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20101413     DOI: 10.1007/s00467-009-1430-4

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  11 in total

1.  Family study of 2,8-dihydroxyadenine stone formation: report of two cases of a compound heterozygote for adenine phosphoribosyltransferase deficiency (APRT*J/APRT*Q0).

Authors:  K Suzuki; S Kobayashi; K Kawamura; T Kuhara; R Tsugawa
Journal:  Int J Urol       Date:  1997-05       Impact factor: 3.369

2.  Identification of a common nonsense mutation in Japanese patients with type I adenine phosphoribosyltransferase deficiency.

Authors:  A Sahota; J Chen; K Asaki; H Takeuchi; P J Stambrook; J A Tischfield
Journal:  Nucleic Acids Res       Date:  1990-10-11       Impact factor: 16.971

3.  Identification of a compound heterozygote for adenine phosphoribosyltransferase deficiency (APRT*J/APART*Q0) leading to 2,8-dihydroxyadenine urolithiasis.

Authors:  N Kamatani; S Kuroshima; H Yamanaka; S Nakashe; H Take; M Hakoda
Journal:  Hum Genet       Date:  1990-10       Impact factor: 4.132

4.  Human adenine phosphoribosyltransferase deficiency. Demonstration of a single mutant allele common to the Japanese.

Authors:  Y Hidaka; S A Tarlé; S Fujimori; N Kamatani; W N Kelley; T D Palella
Journal:  J Clin Invest       Date:  1988-03       Impact factor: 14.808

5.  [2,8-dihydoroxyadenine (DHA) urolithiasis: a case report].

Authors:  Masahiro Shiba; Kiyonori Shimizu; Hiroshi Takatera
Journal:  Hinyokika Kiyo       Date:  2003-08

6.  Detection of the three common mutations of adeninephosphoribosyltransferase deficiency among Japanese.

Authors:  H Higashimoto; A Ouchi; R Kawaguchi
Journal:  Clin Chim Acta       Date:  1995-01-31       Impact factor: 3.786

Review 7.  A case of a compound heterozygote for adenine phosphoribosyltransferase deficiency (APRT*J/APRT*Q0) leading to 2,8-dihydroxyadenine urolithiasis: review of the reported cases with 2,8-dihydroxyadenine stones in Japan.

Authors:  H Takeuchi; Y Kaneko; J Fujita; O Yoshida
Journal:  J Urol       Date:  1993-04       Impact factor: 7.450

8.  Assignment of the gene for adenine phosphoribosyltransferase to human chromosome 16 by mouse-human somatic cell hybridization.

Authors:  J A Tischfield; F H Ruddle
Journal:  Proc Natl Acad Sci U S A       Date:  1974-01       Impact factor: 11.205

Review 9.  [2,8-dihydroxyadenine urolithiasis due to partial deficiency of adenine phosphoribosyltransferase: a case report].

Authors:  T Ohne; A Fujito; K Koga; Y Imaide; M Uchida
Journal:  Hinyokika Kiyo       Date:  1998-10

10.  Renal failure due to 2,8-dihydroxyadenine urolithiasis.

Authors:  M C Greenwood; M J Dillon; H A Simmonds; T M Barratt; J R Pincott; C Metreweli
Journal:  Eur J Pediatr       Date:  1982-07       Impact factor: 3.183

View more
  1 in total

1.  Adenine phosphoribosyltransferase deficiency in children.

Authors:  Jérôme Harambat; Guillaume Bollée; Michel Daudon; Irène Ceballos-Picot; Albert Bensman
Journal:  Pediatr Nephrol       Date:  2012-01-03       Impact factor: 3.714

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.